DE3856214T2 - Diätzusammensetzungen und Verfahren zur Verwendung von Gallsäure aktivierter Lipase - Google Patents
Diätzusammensetzungen und Verfahren zur Verwendung von Gallsäure aktivierter LipaseInfo
- Publication number
- DE3856214T2 DE3856214T2 DE3856214T DE3856214T DE3856214T2 DE 3856214 T2 DE3856214 T2 DE 3856214T2 DE 3856214 T DE3856214 T DE 3856214T DE 3856214 T DE3856214 T DE 3856214T DE 3856214 T2 DE3856214 T2 DE 3856214T2
- Authority
- DE
- Germany
- Prior art keywords
- methods
- bile acid
- activated lipase
- acid activated
- lipase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
- A23C9/1216—Other enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/122,410 US4944944A (en) | 1987-11-19 | 1987-11-19 | Dietary compositions and methods using bile salt-activated lipase |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3856214D1 DE3856214D1 (de) | 1998-08-13 |
DE3856214T2 true DE3856214T2 (de) | 1998-12-17 |
Family
ID=22402581
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3856214T Expired - Lifetime DE3856214T2 (de) | 1987-11-19 | 1988-11-18 | Diätzusammensetzungen und Verfahren zur Verwendung von Gallsäure aktivierter Lipase |
DE3856435T Expired - Lifetime DE3856435T2 (de) | 1987-11-19 | 1988-11-18 | Verwendung von Gallsäure-aktiviertem Lipase als Diätsupplement |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3856435T Expired - Lifetime DE3856435T2 (de) | 1987-11-19 | 1988-11-18 | Verwendung von Gallsäure-aktiviertem Lipase als Diätsupplement |
Country Status (8)
Country | Link |
---|---|
US (1) | US4944944A (de) |
EP (2) | EP0317355B1 (de) |
JP (2) | JP2592939B2 (de) |
AT (2) | ATE167982T1 (de) |
DE (2) | DE3856214T2 (de) |
ES (2) | ES2120402T3 (de) |
GR (1) | GR3035093T3 (de) |
HK (2) | HK1023031A1 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200183A (en) * | 1987-11-19 | 1993-04-06 | Oklahoma Medical Research Foundation | Recombinant bile salt activated lipases |
US4944944A (en) * | 1987-11-19 | 1990-07-31 | Oklahoma Medical Research Foundation | Dietary compositions and methods using bile salt-activated lipase |
US5000975A (en) * | 1988-12-29 | 1991-03-19 | American Home Products Corporation | Randomized palm oil fat composition for infant formulas |
US5008120A (en) * | 1989-07-21 | 1991-04-16 | Snow Brand Milk Products Co., Ltd. | Method of preparing iron-fortified beverage |
US5173408A (en) * | 1989-11-13 | 1992-12-22 | Lange Louis George Iii | Mammalian pancreatic cholesterol esterase |
JP2808166B2 (ja) * | 1990-04-26 | 1998-10-08 | 雪印乳業株式会社 | 鉄強化飲料の製造方法 |
US5186961A (en) * | 1991-03-15 | 1993-02-16 | North Carolina State University | Method and composition for maintaining animals on a keratin-containing diet |
US5169666A (en) * | 1991-11-14 | 1992-12-08 | The United States Of America As Represented By The Secretary Of Agriculture | Preparation of simulated human milk protein by low temperature microfiltration |
US5902617A (en) * | 1992-05-19 | 1999-05-11 | Pabst; Patrea L. | Enzyme supplemented baby formula |
US5616483A (en) * | 1992-06-11 | 1997-04-01 | Aktiebolaget Astra | Genomic DNA sequences encoding human BSSL/CEL |
GB9212511D0 (en) * | 1992-06-12 | 1992-07-22 | Cortecs Ltd | Pharmaceutical compositions |
US5260074A (en) * | 1992-06-22 | 1993-11-09 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
US5460812A (en) * | 1992-06-22 | 1995-10-24 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
IS4130A (is) * | 1993-03-01 | 1994-09-02 | Ab Astra | Ný fjölpeptíð |
US5696087A (en) * | 1994-12-01 | 1997-12-09 | Oklahoma Medical Research Foundation | Method and compositions for reducing cholesterol absorption |
US5681819A (en) * | 1994-12-01 | 1997-10-28 | Oklahoma Medical Research Foundation | Method and compositions for reducing cholesterol absorption |
US5821226A (en) * | 1994-12-01 | 1998-10-13 | Oklahoma Medical Research Foundation | BAL C-tail drug delivery molecules |
US6342218B1 (en) | 1997-02-14 | 2002-01-29 | Oklahoma Medical Research Foundation | Method for treatment of SLE |
US8828432B2 (en) | 1996-10-28 | 2014-09-09 | General Mills, Inc. | Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles |
US7008776B1 (en) * | 1996-12-06 | 2006-03-07 | Aventis Pharmaceuticals Inc. | Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol |
CA2273823C (en) | 1996-12-06 | 2007-06-05 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Polypeptides encoded by a human lipase-like gene, compositions and methods |
ATE438305T1 (de) | 1998-03-23 | 2009-08-15 | Gen Mills Inc | Verkapselung von komponenten in essbaren produkten |
US7201923B1 (en) | 1998-03-23 | 2007-04-10 | General Mills, Inc. | Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
US6399090B1 (en) * | 1998-06-05 | 2002-06-04 | Insotech Ltd. | Insulin supplemented infant formula |
ATE413889T1 (de) * | 1998-06-05 | 2008-11-15 | Nutrinia Ltd | Insulin angereichertes säuglingsnährpräparat |
AU5032600A (en) * | 1999-05-19 | 2001-12-03 | Barnes-Jewish Hospital | Enhanced triglyceride digestion in a deficiency of bile salts |
EP1059041A1 (de) * | 1999-06-07 | 2000-12-13 | Universiteit Gent | Kombinierte Verwendung von Triglyceriden mit mittelkettigen Fettsäuren und exogenen lipolytischen Enzymen als Futterzusätze |
US6500463B1 (en) | 1999-10-01 | 2002-12-31 | General Mills, Inc. | Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
US6468568B1 (en) | 2000-06-16 | 2002-10-22 | General Mills, Inc. | Oligosaccharide encapsulated mineral and vitamin ingredients |
US6436453B1 (en) | 2000-06-16 | 2002-08-20 | General Mills, Inc. | Production of oil encapsulated minerals and vitamins in a glassy matrix |
US6558718B1 (en) | 2000-06-19 | 2003-05-06 | General Mills, Inc. | Nutrient clusters for food products and methods of preparation |
US7381404B2 (en) * | 2002-07-02 | 2008-06-03 | The Regents Of The University Of California | Treatment for dry macular degeneration |
US7431986B2 (en) | 2002-07-24 | 2008-10-07 | General Mills, Inc. | Encapsulation of sensitive components using pre-emulsification |
CA2889013C (en) | 2003-03-07 | 2018-07-17 | Dsm Ip Assets B.V. | Hydrolases, nucleic acids encoding them and methods for making and using them |
US7803413B2 (en) | 2005-10-31 | 2010-09-28 | General Mills Ip Holdings Ii, Llc. | Encapsulation of readily oxidizable components |
US8071089B2 (en) * | 2005-11-01 | 2011-12-06 | Bio-Cat, Inc. | Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency |
US20090324574A1 (en) | 2006-02-02 | 2009-12-31 | Verenium Corporation | Esterases and Related Nucleic Acids and Methods |
AR059692A1 (es) * | 2007-03-01 | 2008-04-23 | Adriana Fernandez | Alimento de alto contenido calorico y de facil digestion |
US8153391B2 (en) | 2008-08-29 | 2012-04-10 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
US8198062B2 (en) * | 2008-08-29 | 2012-06-12 | Dsm Ip Assets B.V. | Hydrolases, nucleic acids encoding them and methods for making and using them |
US8357503B2 (en) | 2008-08-29 | 2013-01-22 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
ES2603328T3 (es) * | 2010-10-21 | 2017-02-27 | Swedish Orphan Biovitrum Ab (Publ) | Método para incrementar la tasa de crecimiento de lactantes humanos |
CN103189070A (zh) * | 2010-10-21 | 2013-07-03 | 瑞典孤儿比奥维特鲁姆有限公司 | 增加人婴儿对不饱和脂肪酸之吸收的方法 |
KR102425963B1 (ko) | 2012-02-17 | 2022-07-28 | 알크레스타, 인크. | 식이 지방산 수요를 공급하기 위한 방법들, 조성물들 및 디바이스들 |
GB201501081D0 (en) | 2015-01-22 | 2015-03-11 | Cilian Ag | Use of enzymes with a wide pH activity range as medicaments for promoting digestion |
US10258590B2 (en) | 2015-10-14 | 2019-04-16 | Alcresta Therapeutics, Inc. | Enteral feeding device and related methods of use |
MX2018011512A (es) | 2016-03-24 | 2019-02-07 | Nutrinia Ltd | Uso de insulina para promover el vaciamiento gástrico. |
US11045396B2 (en) | 2017-08-17 | 2021-06-29 | Alcresta Therapeutics, Inc. | Devices and methods for the supplementation of a nutritional formula |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA662815A (en) * | 1963-05-07 | G. Farnham Merle | Treatment for "scours" in mammals | |
US3256150A (en) * | 1964-04-20 | 1966-06-14 | Dairyland Food Lab | Method for treating malabsorption syndrome |
US3991180A (en) * | 1972-03-06 | 1976-11-09 | Rohm And Haas Company | Stabilization of internally administered pancreatic lipase |
JPS5017559B2 (de) * | 1972-09-20 | 1975-06-21 | ||
GB1509866A (en) * | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
DE2638089C2 (de) * | 1976-08-24 | 1985-04-25 | Degussa Ag, 6000 Frankfurt | Lipase-Präparate mit verbesserter Wirkung |
GB1571877A (en) * | 1978-04-24 | 1980-07-23 | Meito Sangyo Kk | Microbial lipase and its preparation |
JPS6047858B2 (ja) * | 1978-09-20 | 1985-10-24 | 田村 輝 | 温浴用水製造装置 |
DE2923279B1 (de) * | 1979-06-08 | 1980-11-20 | Kali Chemie Pharma Gmbh | Verfahren zur Herstellung von Pankreatin-Pellets |
EP0188067B1 (de) * | 1985-01-09 | 1992-05-27 | Genencor, Inc. | Überführung von exogenen Stoffen in Käsebruch |
US4944944A (en) * | 1987-11-19 | 1990-07-31 | Oklahoma Medical Research Foundation | Dietary compositions and methods using bile salt-activated lipase |
-
1987
- 1987-11-19 US US07/122,410 patent/US4944944A/en not_active Expired - Lifetime
-
1988
- 1988-11-18 ES ES88310942T patent/ES2120402T3/es not_active Expired - Lifetime
- 1988-11-18 JP JP63293447A patent/JP2592939B2/ja not_active Expired - Lifetime
- 1988-11-18 ES ES93203480T patent/ES2152941T3/es not_active Expired - Lifetime
- 1988-11-18 AT AT88310942T patent/ATE167982T1/de not_active IP Right Cessation
- 1988-11-18 EP EP88310942A patent/EP0317355B1/de not_active Expired - Lifetime
- 1988-11-18 DE DE3856214T patent/DE3856214T2/de not_active Expired - Lifetime
- 1988-11-18 EP EP93203480A patent/EP0605913B1/de not_active Expired - Lifetime
- 1988-11-18 AT AT93203480T patent/ATE197127T1/de not_active IP Right Cessation
- 1988-11-18 DE DE3856435T patent/DE3856435T2/de not_active Expired - Lifetime
-
1994
- 1994-01-05 JP JP6000168A patent/JPH06315347A/ja active Pending
-
1998
- 1998-12-15 HK HK00100453A patent/HK1023031A1/xx not_active IP Right Cessation
- 1998-12-15 HK HK98113370A patent/HK1012213A1/xx not_active IP Right Cessation
-
2000
- 2000-12-18 GR GR20000402781T patent/GR3035093T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3856435D1 (de) | 2000-11-30 |
ATE197127T1 (de) | 2000-11-15 |
HK1023031A1 (en) | 2000-08-25 |
EP0317355A3 (de) | 1991-07-17 |
ES2120402T3 (es) | 1998-11-01 |
JPH01231848A (ja) | 1989-09-18 |
EP0317355A2 (de) | 1989-05-24 |
GR3035093T3 (en) | 2001-03-30 |
HK1012213A1 (en) | 1999-07-30 |
US4944944A (en) | 1990-07-31 |
EP0317355B1 (de) | 1998-07-08 |
JP2592939B2 (ja) | 1997-03-19 |
EP0605913A1 (de) | 1994-07-13 |
ATE167982T1 (de) | 1998-07-15 |
DE3856435T2 (de) | 2001-03-29 |
JPH06315347A (ja) | 1994-11-15 |
ES2152941T3 (es) | 2001-02-16 |
EP0605913B1 (de) | 2000-10-25 |
DE3856214D1 (de) | 1998-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3856214D1 (de) | Diätzusammensetzungen und Verfahren zur Verwendung von Gallsäure aktivierter Lipase | |
ATE73658T1 (de) | Diaetzusatz zur verminderung der gefahr einer infektion. | |
US6699496B1 (en) | Enzyme in a dosage form for oral use in mammals, enzyme-containing food material and method for administering the enzyme in a dosage form | |
ATE79544T1 (de) | Zusammensetzungen zur behandlung von hypercholesterinaemie. | |
DE3570362D1 (en) | Pharmaceutical or dietetic composition having a high antithrombotic and antiarteriosclerotic activity | |
AU1983488A (en) | Method and composition for increasing the concentration of omega-3, polyunsaturated fatty acids in poultry and poultry eggs and poultry and eggs resulting therefrom | |
DE3888408D1 (de) | Fettemulsion, Verfahren zu ihrer Herstellung und ihre Verwendung. | |
DE69224124D1 (de) | Verfahren zur Herstellung von Dihomo-Gamma-Linolensäure und das in dieser enthaltende Lipid | |
ATE212194T1 (de) | Nahrungsprodukt zur behandlung der ulzerativen kolitis sowie verwendung desselben | |
SE8701847L (sv) | Etliga fetter | |
DE3768138D1 (de) | Substituierte pyrimidinamide von oelsaeure oder linolsaeure als inhibitoren von acyl-coa cholesterin-acyltransferase. | |
Borel et al. | Gastric lipase: evidence of an adaptive response to dietary fat in the rabbit | |
ES2037265T3 (es) | Nuevo aceite dietetico. | |
AU1489688A (en) | Omega-3 fatty acids in traumatic injury treatment | |
DE69813600D1 (de) | Verfahren zur erhöhung der konzentration von konjugierter linolsäure in milch und/oder fettgewebe eines wiederkäuers | |
Suttie et al. | Fat utilization in the fluoride-fed rat | |
Blaton et al. | The human plasma lipids and lipoproteins under influence of EPL-therapy | |
EP0187653A3 (en) | Pharmaceutical compositions replacing the bile and aidinpharmaceutical compositions replacing the bile and aiding the digestion of fats, and process for their preparatig the digestion of fats, and process for their preparation on | |
SE8800101D0 (sv) | Anvendning av essentiella fettsyror for framstellning av ett preparat for behandling av eksem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |